by The Peptide Library | Aug 27, 2025 | Weight Loss & Metabolism
Tirzepatide vs. Semaglutide (Ozempic/Wegovy) The conversation around GLP-1–based therapies has shifted dramatically in recent years as new peptides enter the scene. One of the most important debates in the metabolic health field is Tirzepatide vs. Semaglutide. Both...
by The Peptide Library | Aug 27, 2025 | Weight Loss & Metabolism
Tirzepatide for Type 2 Diabetes Management Managing type 2 diabetes effectively requires addressing multiple mechanisms of glucose control. Tirzepatide for type 2 diabetes management has emerged as one of the most promising advancements in the last decade,...
by The Peptide Library | Aug 26, 2025 | Weight Loss & Metabolism
The Science of Tirzepatide for Weight LossIntroduction: If you’re exploring the science of tirzepatide for weight loss, you’re in the right place. Tirzepatide is a once-weekly dual incretin agonist that targets both GLP-1 and GIP receptors. This guide unpacks the...
by The Peptide Library | Aug 26, 2025 | Weight Loss & Metabolism
What is Tirzepatide and How Does It Work?Introduction: If you’ve asked yourself what is tirzepatide and how does it work, you’re not alone. Tirzepatide is a first-in-class, once-weekly “twincretin” that targets both GLP-1 and GIP receptors to improve glucose control...
by The Peptide Library | Aug 21, 2025 | Weight Loss & Metabolism
AOD-9604 Fat-Loss Peptides: Spotlight vs CJC-1295, Ipamorelin, and Tesamorelin AOD-9604 Fat-Loss Peptides are a frequent topic of discussion in peptide research. This spotlight article compares AOD-9604 with CJC-1295, Ipamorelin, and Tesamorelin, exploring mechanisms,...
by The Peptide Library | Aug 21, 2025 | Weight Loss & Metabolism
Legal Status of AOD-9604 Around the World The question of the legal status of AOD-9604 around the world has generated significant debate among researchers, clinicians, and regulatory agencies. Originally developed as an anti-obesity drug fragment, AOD-9604 has since...
